Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Pharmagreen Biotech Inc (PK) | PHBI | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.001 | 08:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.001 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.000195 - 0.0031 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.001 | USD |
Pharmagreen Biotech Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 463.96M | 267.09M | 3k | -569k | -0.00 | 0.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Pharmagreen Biotech (PK) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 8/14/2023 | 15:38 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHBI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.001 | 0.0011 | 0.0009 | 0.0009855 | 725,713 | 0.00 | 0.00% |
| 1 Month | 0.0007 | 0.0014 | 0.0006 | 0.0010807 | 3,213,205 | 0.0003 | 42.86% |
| 3 Months | 0.0006 | 0.0014 | 0.0006 | 0.0009254 | 1,947,034 | 0.0004 | 66.67% |
| 6 Months | 0.0007 | 0.0014 | 0.0005 | 0.0008174 | 1,923,750 | 0.0003 | 42.86% |
| 1 Year | 0.0025 | 0.0031 | 0.000195 | 0.0008043 | 5,999,284 | -0.0015 | -60.00% |
| 3 Years | 0.0241 | 0.0415 | 0.000195 | 0.0041121 | 2,435,194 | -0.0231 | -95.85% |
| 5 Years | 2.10 | 2.50 | 0.000195 | 0.0168411 | 2,802,124 | -2.10 | -99.95% |
Pharmagreen Biotech (PK) Description
| Pharmagreen Biotech Inc. (OTC Markets: PHBI) is developing its line of nutraceutical products, a proprietary blend of therapeutic plants and mushrooms. Pharmagreen's first new product, MaxGenomic(TM) Supplement, is a proprietary blend, formulated in the U. S. A., of nine medicinal mushrooms and six medicinal plants to help support the human mind and body. This supplement is produced in a U.S.A cGMP facility, in enteric capsules to enhance the bioavailability of the MaxGenomic(TM) supplement. Pharmagreen is also completing its research for its elixir, sublingual version, to provide immediate help and support to those who push their mental and physical capacity to their limits. Utilizing the Company's expertise in plant genetics, tissue culture, Pharmagreen's transgenic program uses the current technologies to research and create nutraceutical formulations as daily supplements, with the potential to improve lives and address a wide variety of aliments. |
